Metraipolis › archive › dc_796e16ea1db8

Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management — Europe PMC PMID:42652564

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42652564
DOI
10.3390/jcm15166160
License (as archived)
solo-consultazione
Archived
2026-10-16T22:51:24.235Z
SHA-256 of the archived text
eb93053c8a7323ec014c1e6d76f7abe38eed44186e1b1f123812db94319b03c3
Stable URL of this page
https://metraipolis.com/documento/dc_796e16ea1db8

How to cite

Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management — Europe PMC PMID:42652564 — Europe PMC (en), https://europepmc.org/article/MED/42652564 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_796e16ea1db8 (Metraipolis archive dc_796e16ea1db8, sha256 eb93053c8a7323ec014c1e6d76f7abe38eed44186e1b1f123812db94319b03c3)
BibTeX
@misc{dc796e16ea1db8,
  title = {Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management — Europe PMC PMID:42652564},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652564},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_796e16ea1db8; sha256 eb93053c8a7323ec014c1e6d76f7abe38eed44186e1b1f123812db94319b03c3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652564. Agents can read the archived copy with the MCP tool read_document.